Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 3Phase 3 1Phase 1/2 1

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 7Breast 3Sarcoma 1Other solid neoplasm 1Dermatologic 1

Conditions

Breast Neoplasms 3Malnutrition 1Depression 1Breast Neoplasms, Male 1

Interventions

Trastuzumab 349Paclitaxel 310Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 214Letrozole 185Fulvestrant 178Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 114pembrolizumab 113Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 66Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Mental Status and Dementia Tests × Breast × Clear all
NCT00609791 2026-06-04

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer

City of Hope Medical Center

Phase 2 Active not recruiting
40 enrolled 16 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT02774681 2020-04-14

Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis

Northwestern University

Phase 2 Terminated
12 enrolled 11 charts
Breast

Breast Neoplasms

NCT00424203 2013-09-04

Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

UNICANCER

Phase 2 Completed
40 enrolled
Breast

Breast Neoplasms, Depression, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon âš¡